RxDoctor Payments Data

Redgy Fuller, DO

Anesthesiology · Omaha, NENPI 1891178372

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 77.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $7,256 and has fallen 91.9% since, to $588 in 2025. Among anesthesiology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,402in general payments, 2019–2025

Across 63 payments — averaging $149.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Nevro Corp.$636
  • Abbott$285
  • Saluda Medical Americas, Inc.$279
  • SPR Therapeutics, Inc$207
  • Boston Scientific$179
  • plus $506 from 7 others

What the payments were for

  • Grants$5,00053%
  • Travel & lodging$1,49716%
  • Food & beverage$2,90531%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,402 in reported general payments places this provider in the 95th percentile of 281 anesthesiology providers in Nebraska.

See all anesthesiology providers in Nebraska

Medicare billing

Part B allowed, 2024
$62,684
Medicare patients
162
Services billed
654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin168$2,598
Gabapentin134$1,701
Cyclobenzaprine Hcl62$1,313
Lidocaine14$692
Celecoxib37$577
Duloxetine Hcl49$493
Tizanidine Hcl27$355
Meloxicam51$250
Oxycodone Hcl16$135
Alprazolam17$15

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →